CA2304283A1 - Formulations antiparasitaires - Google Patents

Formulations antiparasitaires Download PDF

Info

Publication number
CA2304283A1
CA2304283A1 CA002304283A CA2304283A CA2304283A1 CA 2304283 A1 CA2304283 A1 CA 2304283A1 CA 002304283 A CA002304283 A CA 002304283A CA 2304283 A CA2304283 A CA 2304283A CA 2304283 A1 CA2304283 A1 CA 2304283A1
Authority
CA
Canada
Prior art keywords
implant
parasiticidal compound
tabletting excipients
parasiticidal
antioxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002304283A
Other languages
English (en)
Inventor
Hiep Huatan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Individual filed Critical Individual
Publication of CA2304283A1 publication Critical patent/CA2304283A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention porte sur un implant solide comprenant au moins un composé antiparasitaire présentant une faible solubilité dans l'eau; et des excipients pour comprimés comprenant un agent gonflant. Les implants de cette invention conviennent pour être administrés, et assurent une protection de longue durée contre les parasites.
CA002304283A 1997-09-23 1998-09-04 Formulations antiparasitaires Abandoned CA2304283A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9720228.7 1997-09-23
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GB9810143.9 1998-05-12
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations
PCT/EP1998/005720 WO1999015166A1 (fr) 1997-09-23 1998-09-04 Formulations antiparasitaires

Publications (1)

Publication Number Publication Date
CA2304283A1 true CA2304283A1 (fr) 1999-04-01

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002304283A Abandoned CA2304283A1 (fr) 1997-09-23 1998-09-04 Formulations antiparasitaires

Country Status (13)

Country Link
EP (1) EP1014970A1 (fr)
JP (1) JP2001517622A (fr)
AP (1) AP9801350A0 (fr)
AR (1) AR013509A1 (fr)
AU (1) AU9742298A (fr)
BR (1) BR9812385A (fr)
CA (1) CA2304283A1 (fr)
GT (1) GT199800149A (fr)
MA (1) MA24655A1 (fr)
PA (1) PA8459501A1 (fr)
PE (1) PE117199A1 (fr)
TN (1) TNSN98175A1 (fr)
WO (1) WO1999015166A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
WO2001037811A1 (fr) * 1999-11-22 2001-05-31 Akzo Nobel N.V. Compositions permettant de liberer un ingredient actif de façon predefinie et regulee, preparation et utilisation de ces compositions
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
WO2018226512A1 (fr) * 2017-06-06 2018-12-13 Merck Sharp & Dohme Corp. Implant à action prolongée pour le traitement de maladies infectieuses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (fr) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectine comme agents pour promotion de la croissance
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
PE117199A1 (es) 1999-11-20
TNSN98175A1 (fr) 2005-03-15
JP2001517622A (ja) 2001-10-09
MA24655A1 (fr) 1999-04-01
AP9801350A0 (en) 2000-03-17
BR9812385A (pt) 2000-09-12
AR013509A1 (es) 2000-12-27
PA8459501A1 (es) 2000-05-24
WO1999015166A1 (fr) 1999-04-01
EP1014970A1 (fr) 2000-07-05
GT199800149A (es) 2000-03-15
AU9742298A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
US5439924A (en) Systemic control of parasites
EP1035835B1 (fr) Formulations injectables a action prolongee renfermant de l'huile de ricin hydrogenee
US6653288B1 (en) Injectable anthelmintic compositions and methods for using same
CA2351730C (fr) Formulations antiparasitaires contenant de l'avermectin 13-monosaccharide 5-oxime
CA2304283A1 (fr) Formulations antiparasitaires
JPH0672108B2 (ja) 水素化ひまし油を含む長期持続性注射製剤
KR20100020003A (ko) 안정한 비수성 외용제 조성물
AU660205B2 (en) Systemic control of parasites
KR20150094643A (ko) 향상된 수용성 및 우수한 저장 안정성을 가지는 정제
EP3609470B1 (fr) Implants pour traiter les infestations de parasites
CN110022862B (zh) 药物制剂及其制造方法
CN1822880B (zh) 杀灭寄生物的组合物
EP2598151B1 (fr) Compositions pour le traitement de ver du coeur
MXPA00002843A (en) Parasiticidal formulations
US6953586B1 (en) Growth promoting pharmaceutical implant
HK40011796A (en) Pharmaceutical preparation and method for its manufacture
HK40099580A (zh) 适口调配物
MX2014010957A (es) Composiciones de accion prolongada.
HK1096621B (en) Parasiticidal composition
HU208252B (en) Process for producing solution against parasites and comprising avermectin derivative

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead